ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda’s Entyvio achieves superior remission than Humira in ulcerative colitis
March 13, 2019Takeda has announced results from Phase IIIb head-to-head study of two biologic therapies, Entyvio (vedolizumab) and adalimumab, the generic of AbbVie’s Humira, in which Entyvio achieved statistically significant clinical remission in patients with modera
Pharma Sources Insight January 2025
